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Abstract
Non-PH parametric survival modelling is developed within the framework of the mul-
tiple logistic function. The family considered comprises three basic models: (a) a PH
model, (b) an accelerated life model and (c) a model which is non-proportional haz-
ards and non-accelerated life. The last model, the generalised time-dependent logistic
model was described first by the author in 1996 and this model gives its name to
the entire family. The family is generalised by means of a Gamma frailty extension
which is shown to accommodate crossing hazards data. A further generalisation is the
inclusion of a dispersion model. These extensions lead naturally to the concept of a
multi-parameter regression model described by Burke and MacKenzie in which the
scale and shape parameters are modelled simultaneously as functions of covariates.
Where possible, we include the MPR extension in the XGTDL family. Following a
simulation study, the new models are used to analyse two sets survival data and the
methods are discussed.
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1 Introduction
Prior to the development of the proportional hazards (PH) survival model, epi-
demiologists worked with the multiple logistic function in prospective longitudinal
studies where the follow-up duration was fixed, e.g. in relation to disease incidence
(Cox 1970). Not all incidence data conform to the PH assumption and MacKenzie
(1996) introduced a family of survival models based on the multiple logistic function
which specifically recognised this fact. The generalised time-dependent logistic family
(GTDL) comprised three models (a) a PH model, (b) an accelerated life (AL) model
and (c) a model which is non-PH and non-AL. Development was focussed on model
(c), designated the GTDL model, and a Gamma extension demonstrated its ability
to deal with crossing hazards survival data (MacKenzie and Ha 2007). This exam-
ple involved the creation of a covariate-dependent shape parameter. Accordingly, the
idea of modelling the shape parameter more generally intrudes and this has motivated
the development of multi-parameter regression (MPR) survival models (Burke and
MacKenzie 2013, 2017). In this paper,we extend theGTDLfamily to theXGTDLfam-
ily (‘X’ for extended) by including: (a) Gamma frailty, (b) a dispersion model for the
frailty variance, and where possible, (c) a MPR model to model non-PH survival data.
2 The GTDL family
TheGTDL family of regression survivalmodelswas predicated on themultiple logistic
function and the defining hazard functions of the three models in the family are as
follows:
(a) The logistic PH model (LPH)
λ(t; x) = π(tα + γ0)ϕ, (1)
where π(·) = exp(·)/[1 + exp(·)] and the hazard function is λ(·) > 0 and the
following scalers are defined as: α, γ0 ∈ (−∞, +∞), and ϕ = exp(x ′β) > 0.
There is no intercept term in the linear predictor in ϕ, in keeping with Cox’s PH
model (Cox 1972).
(b) The logistic AL model (LAL)
λ(t; x) = λϕπ(αϕt), (2)
where π(·), α and ϕ are defined above and λ > 0 is a scalar.
(c) The GTDL model (TDL when λ0 = 1 )
λ(t; x) = λ0π(tα + γ ), (3)
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where π(·) and α are defined above and λ0 > 0 is a scalar. Here, γ = x ′β and x ′
includes an intercept term x0. This model is neither PH nor AL.
2.1 Some remarks
Remark 1 Whilst we are principally interested in non-PH survival, model (a) is
included for the sake of completeness. It has a very simple interpretation in which
the baseline hazard is a linear logistic function of time and the hazard function is
clearly unbounded above.
Remark 2 Model (b) is rather more complicated and it was developed specifically to
avoid having a bounded hazard function (Al-tawarah and MacKenzie, 2003). It was
derived by accelerating the baseline survivor function,which is obtained from equation
(2), by first setting x ′ = zero vector (whence ϕ = 1) and integrating to obtain the
baseline integrated hazard. In particular, the scalar α parameter was introduced to
allow for negative trends.
Remark 3 In many ways, model (c) is the most interesting, but its development was
not straightforward. The constant λ0, introduced to avoid having a bounded hazard
function, transpired to be inestimable in maximum likelihood estimation (MLE) anal-
ysis as it is aliased with the intercept term β0 in the linear predictor γ . One approach
was to drop the intercept term (MacKenzie 2002; Blagojevic et al. 2003), in which
case all of the parameters are estimable in MLE. This model was termed the canonical
form and designated CTDL.
This idea seemed to work, but in fact it led to a more insidious problem, namely
the lack of invariance of the model to the choice of reference subclass when fitting
categorical covariates.Moreover, this problemwas undetectable when the total sample
size was less than 1000 andmight well have been overlooked completely. Surprisingly,
the solution to this problem (which does not occur with continuous covariates) is to
permit λ0 to vary, for example, with individuals as a Gamma frailty term. Prior to this
solution, the GTDLmodel was used successfully with λ0 = 1, when it was designated
the TDLmodel. However, today, the Gamma frailty extension is preferred (Blagojevic
et al. 2003; MacKenzie and Ha 2007; Ha and MacKenzie 2010). 
Later, we extend the entire family to incorporate Gamma frailty in which case all
the models will be non-PH.
2.2 Survival functions
Corresponding to Eqs. (1)–(3), we have the survivor functions:
(a) The LPH model
S(t; x) =
[




where ϕ = exp(x ′β).
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where c = 1/2 and ϕ = exp(x ′β).
(c) The GTDL model
S(t; x) =
[
1 + exp(tα + γ )
1 + exp(γ )
]−λ0/α
, (6)
where γ = x ′β (including an intercept) is a scale parameter. Again when fitting
this model we shall specialise λ0 = 1, the TDL.
2.3 Cure fractions
It may be verified that the behaviour of the survival functions is determined by the
value of α. Typically, for α > 0, S(0|x) = 1 and S(∞|x) = lim
t−→∞ S(t |x) = 0,
in other words, the survival function is proper, but for α < 0, S(0|x) = 1 and
lim
t−→∞ S(∞|x) = 0. Then, the survival function is improper, and in each case, we
have a natural tail-deficit or cure rate model. We do not pursue the technical details
of cure models in the XGTDL family here, but draw attention to related work by
Milani et al. (2015), who studied the tail-deficit GTDL and the tail-deficit GTDL with
Gamma frailty, while Rasouli et al. (2016) studied a GTDL model as a classical cure
rate mixture model and Calsavara et al. (2020) analysed a melanoma dataset.1
3 Frailty extension
Standard arguments involving an unobservable, multiplicative, random effect, u (> 0),
on the hazard function yields the general formulae for themarginal survivor and hazard
functions, viz.






1 + φ (t) , (8)
respectively.
Here S(t),(t) and ∂(t)∂t = λ(t) are the basic survival quantities. More-
over, L[s] = E(e−sU ) = L[(t)] with s = (t) is the Laplace transform and
1 Surprisingly, this latter paper omits key earlier references covered here.
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U is the random variable generating the random effect, u, with density g(u) =
[φ 1φ (1/φ)]−1u 1φ −1 exp(−u/φ), where E(U ) = 1 and V (U ) = φ. It is convenient
to write φ = exp(ψ) > 0.
We use these formulae to incorporate a Gamma frailty (GF) extension in all three
members of the GTDL family in turn.
(a) LPH with Gamma frailty
The marginal survivor function is given by
Sm(t; x) = [1 + φ α−1ϕ loge R(t)]−
1
φ (9)
with corresponding marginal hazard function
λm(t; x) = π(tα + γ0)ϕ[1 + φ α−1ϕ loge R(t)]
, (10)
where R(t) = [1 + exp(tα + γ0)]/[1 + exp(γ0)] and regression parameter ϕ =
exp(x ′β).
(b) LAL with Gamma frailty
The marginal survivor function is given by
Sm(t; x) =
[









with corresponding marginal hazard function









where, as before, the regression is held in ϕ = exp(x ′β).
(c) GTDL with Gamma frailty








with corresponding marginal hazard function




where R(t; x) = [1+ exp(tα +γ )]/[1 + exp(γ )] and γ = x ′β. Here λ0 does not
appear as it was replaced by the frailty term, u, and integrated out (see Remark 3
in Sect. 2.1 for more explanation). 
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Thus, all three members of the GTDL family now incorporate frailty and are fully
parametric, non-PH, survival models capable of further extension.
4 Frailty dispersionmodel
The use of Gamma frailty can be justified on the grounds of mathematical convenience
(the probability density function of the marginal distribution can always be found
analytically) and on the flexible range of shapes allowed by the Gamma distribution.
However, it is sometimes argued that a single Gamma distribution does not afford
sufficient flexibility. Accordingly, the flexibility can be extended by allowing the frailty
variance to become a person-specific quantity, via another regression model, i.e.
φi = exp(wTi ψ), (15)
where wTi = (w0i , w1i , w2i , . . . , wri ) and ψ = (ψ0, ψ1, ψ2, . . . , ψr )T are vectors
(of order r + 1) of person-specific covariates and regression coefficients, respectively,
and w0i = 1, for i = 1, 2, . . . , n, where n is the sample size.
Thus, the dispersion model (DM) is regression-based and hence driven by the
data. When a DM is required, it relaxes the assumption that a single Gamma frailty
distribution is sufficient. For example, if a binary covariate is supported by the data
in the DM we shall have two GF distributions and when the frailty variance does
not depend on covariates the model reduces to the standard frailty model viz: φi =
exp(w0i × ψ0) = exp(ψ0) the same constant for each person.
The concept of modelling the structure of the dispersion has been addressed in the
joint mean-dispersion modelling literature (Smyth 1989; Lee and Nelder 2001; Pan
and MacKenzie 2003), but its adoption in the frailty paradigm, in survival analysis, is
more recent (Lynch and MacKenzie 2014). Furthermore, the use of frailty dispersion
modelling in combination with an underlying GTDL family MPR model (below) is
novel in the survival literature.
With the dispersionmodel in place we have in effect created the core of the XGTDL
family. In the next section we extend the family further using the ideas of MPR
modelling.
5 MPRmodelling
Following Burke and MacKenzie (2017), the key idea is to model the scale and shape
parameters simultaneously in terms of the covariates. Again, this idea is relatively new
in the survival literature and is best illustrated by a familiar example. We start with
the MPRWeibull (WB) model which is non-PH and used later as a comparator for the
MPR models which we develop later in the XGTDL family.
5.1 TheWeibull MPRmodel
The Weibull hazard function (Collett 2003) is λ(t) = λγ tγ−1 with (λ > 0 and > 0)
whence the MPR form is simply: loge γ = z′α (shape) and loge λ = x ′β (scale)
123
Japanese Journal of Statistics and Data Science
resulting in the MPR hazard function
λ(t; x, z) = exp(x ′β) exp(z′α)texp(z′α)−1,
a non-PH model in which x = (x0, x1, x2, . . . , xp) and z = (z0, z1, z2, . . . , zq).
When x and z contain the same covariates, including intercepts, q = p. When
α = (α0, α1, α2, . . . , αq) = 0 the model reduces to an Exponential model (PH)
with parameter ϕ. And when α = (α0, 0, 0 . . . , 0) the model is a standard Weibull
model (PH) in which α0 is the shape parameter. Inference in theMPRWeibull model is
discussed in detail by Burke andMacKenzie (2017) and awide range of two-parameter
MPR survival models can be fitted using the mpr package developed by Burke (2016)
in R (Core 2018).
With these arrangements in place, we can apply theMPR concept to existingmodels
in the XGTDL family. It is worth noting that any model with more than one linear
predictor is an MPR model, e.g. a Weibull regression model with a constant shape
parameter and a Gamma frailty dispersion model.
5.2 Amotivating example
We can gain some insight into the flexibility of MPR models by analysing the data
provided by the Gastrointestinal Tumor Study Group (Schein and Lombard et al.
1982). This was a randomised controlled trial of the effects of two treatment regimens:
chemotherapy vs combined chemotherapy and radiotherapy on the survival times of
90 (45 per regimen) gastric cancer patients. The resulting Kaplan and Meier (1958)
survival curves are shown in Fig. 1. The survival curves cross indicating the presence of
crossing hazards (violating theCox (1972) PH assumption) and a significant difference
in survival between groups (MacKenzie and Ha 2007). Early survival (0–2 years) is
better in the chemotherapy group while longer term survival is better in the combined
therapy group.
Table 1 shows a number of different parametric models (one PH and the rest non-
PH) fitted to the data. Inspecting the treatment effects (the β̂1s) in Table 1, the TDL +
MPR +GFmodel with Gamma frailty and separate shape parameters (the α̂s) shows a
clear and statistically significant treatment effect. The WB +MPR + GF model shows
a marginal result (t = −0.869/0.432 = −2.01) for the treatment effect, but the AIC
for the TDL + MPR + GF model is much superior, suggesting that a non-PH base
survival function is also required.
It also clear that Gamma frailty is important—theWB + GFmodel almost detects a
difference in treatment effect (t = −1.006/0.508 = −1.98) but the TDL + GF result
is unequivocal (t = −3.288/0.822 = −4.0). However, neither of these models can fit
the crossing hazards data in Fig. 1. That requires an MPR model with separate tracks
for each group.
Looking at the othermodels in Table 1would lead one to conclude, erroneously, that
there was no statistically significant difference between survival in the two treatment
groups. This finding highlights the need for graphical confirmation of tableau results.
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Fig. 1 GTSG crossing hazards
data: KM survival by treatment
group. Chemo. = lower-tailed
curve (red) and Chemo.+
radiotherapy = higher tailed
curve (black)
Figure 2 shows the resulting goodness-of-fit of the TDL + MPR + GF model. The
model fits the survival data in both treatment groups well and captures the crossing
point of the survival functions. It is apparent that the goodness-of-fit lies, in large part,
in modelling the shape parameters in each treatment arm. Accordingly, it is but a short
step to consider that modelling the shape parameters may be a useful stratagem in
general.
6 XGTDL–MPR GFmodels
We have already seen above that the standard two-parameter Weibull survival model
can be extended to MPR form (Burke and MacKenzie 2017) and that the TDL + GF
model can be extended (MacKenzie and Ha 2007). However, in general, it is still an
open question as to whether all two-parameter survival models permit this extension.
Accordingly, we turn now to systematically develop the MPR models in the XGTDL
family. For convenience we assume that x contains the same covariates as z, whence
q = p.
(a) The LPH + MPR + GF model
The LPHmodel with Gamma frailty is easily extended toMPR form bymodelling
the α parameter in (9). We choose
α = α0z0 + α1z1 + α2z2+, . . . ,+αpz p, (shape)
ϕ = exp(β1x1 + β2x2+, . . . ,+βpxp), (scale) (16)
where, in the shape parameter, α0 can be negative, representing a declining hazard
function (MacKenzie 1996). Note that the scale parameter ϕ is unchanged.
(b) The LAL + MPR + GF model
123
Japanese Journal of Statistics and Data Science
Table 1 GTSG crossing hazards data: Weibull and TDLmodels fitted; ML estimates, standard errors (S.E.)
and AICs
It may be thought that the LAL model with Gamma frailty could be extended to
MPR form in a similar fashion, but in this AL model the parameter
ϕ = exp(β1x1 + β2x2+, . . . ,+βpxp) (shape and scale)
influences both shape and scale. From (10), we see that the only other free param-
eter which could be given a linear predictor is λ, but this, too, influences the scale.
Attempts to implement such a MPRmodel produced unstable results and we omit
this development.
(c) The TDL + MPR + GF model
The TDL model with Gamma frailty is extended to MPR form as follows
α = α0z0 + α1z1 + α2z2+, . . . ,+αpz p, (shape)
γ = β0x0 + β1x1 + β2x2+, . . . ,+βpxp. ( scale) (17)
and λ0 has been replaced by the frailty term and integrated out so we refer to this
model as TDL rather than GTDL. Note also that the definition of γ is unchanged.

With these arrangements, the α parameter has become person-specific via the
regression so that each subject has a separate covariate-dependent shape parameter.
In this way, shape is modelled symmetrically with scale. Clearly, the same scheme
applies equally to MPR models without Gamma frailty e.g. the LPH + MPR model.
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Fig. 2 GTSGcrossing hazards data:KMandmodel-based survival by treatment groups;KM= step function,
Model = smooth curve, KM confidence interval = dots. The fitted model is TDL + MPR + GF, Table 1
7 Estimation and fitting
Model formulation may be quite detailed in the XGTDL family, but, fortunately,
Maximum Likelihood (ML) estimation in parametric survival models is classical and
straightforward. We assume that the observed survival time, t = min(t1, t2), where
t1 is distributed as a XGTDL random variable, T1, and T2 is a chosen censoring
distribution such that T1 is statistically independent of T2. For data (ti , di , xi ), where
i = 1, 2, . . . , n subjects and with independent censoring, the likelihood for the param-
eters, say θ , is
L(θ) =
∏
[λ(ti ; xi , θ)di S(ti ; xi , θ)], (18)
where di is the censoring indicator with di = 1 for an event and di = 0 for a censored
observation. The hazard functions and survival functions for all of the models in the
XGTDL family have been provided in foregoing sections.
We fitted the models using a specially written R programme (Core 2018) which
called the numerical optimisation procedure nlm to maximise the log-likelihood func-
tion, compute the maximum likelihood estimators and their standard errors from the
observed information matrix.
8 Model selection
In the XGTDL family, there are three model classes, LPH, LAL and TDL. For the
purpose of selecting amongst models within a class, standard information criteria may
be used. We opted for the use of the Akaike (1974) information criterion, AIC =
−2 log(θ̂)+2 dim(θ̂), where θ̂ is the maximum likelihood estimator and dim(θ̂) is the
number of parameters to be estimated. There are two levels of model selection, both
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of which can be handled by the AIC, namely: (a) covariate selection within a single
model type (within a class) and (b) model type selection across classes.
In the three classes, there are 6 + 3 + 6 = 15 model types in all. To see this, let
the base = LPH or LAL or TDL basic regression survival models. Then, for the LPH
and TDL classes, we have: (1) base, (2) base + GF, (3) base + DM, (4) base + MPR,
(5) base + MPR + GF, (6) base + MPR + DM. And for the LAL class, we have the
first three model types only. To this, we can add another 6 models with base = WB
(Weibull) as comparators making 21models in all, and not space enough to present the
findings for the whole family in the paper. Accordingly, we present only an example
simulation.
Theuse of theAICmaypre-suppose that one is prepared, á priori, to fit severalmodel
classes. However, a great deal may be done, initially, by classical plotting methods:
for example, by plotting model-based survival functions and/or the cumulative hazard
functions against time and comparing with their non-parametric counterparts. In this
way, the adequacy of the functional formof the base regressionmodelmay be assessed.
Next, a check for possible shape effects would seem reasonable. Finally, the addition
of gamma frailty might be considered on the grounds that the current regression may
not be completely comprehensive. At each stage the AIC and the fit of the survival
function can be checked for improvement.
9 Simulation study
We conducted the simulation with: two covariates x1 (continuous, N (0, 1)) and x2
(binary, 50% split); three sample sizes (n = 200, 500 and 1000); three censoring rates
(10, 20 and 50%); three values of the frailty variance φ (0.5, 1 and 1.5) and finally for
three different parameter vectors. Thus, there were 81 scenarios in principle for each
model and the number of replications was m = 1000.
In the simulations, the proportion of right (random) censoring, pc, was controlled
using an exponential distribution where the value of the controlling parameter, ϑ̂ , was
obtained from the J (·) function approach. Suppose the independent censoring times




S(t; θ)g(t;ϑ)dt − pc
]2
for fixed θ and a required censoring proportion, pc. Then, we find ϑ̂ = argmin[J (ϑ)].
These minimizations were carried out in the R statistical package (Core (2018)) using
the optimize procedure. The function S(t; θ) is, XGTDL family, model-specific.
We emphasise that the purpose of these simulations is simply to ensure that the
parameters are recoverable in the scenarios studied and to ascertain the level of bias
(if any). The true values of the parameters are shown at the bottom of the table.
Table 2 shows the results for TDL + MPR + GF model. The bias is generally small
and decreases with increasing sample size in the scale and shape parameters. The
frailty variance is φ = exp(ψ0 = −0.7) = 0.5. However, for the smallest sample size
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Table 2 Simulation: ML estimates, estimated standard errors (S.E.) and percentage bias for the TDL,MPR,
Gamma frailty model with different sample sizes and censoring rates
(n = 200), some estimates can be biased, but the bias is much reduced for increasing
sample sizes and small when n = 1000. Of course, we expect that more complicated
models tend to require larger sample sizes, but, overall, our simulation suggests that
the model parameters are recoverable for reasonable sample sizes.
We also computed the probabilities that the intervals I j = [a j , b j ], for j =
1, . . . ,m(= 1000) replications, covered the true value of the corresponding param-
eter, say θ j , where a j , b j = θ̂ j ∓ 2 × se(θ̂ j ), respectively. Setting c j =1 when I j
covers θ j and c j = 0, otherwise, the estimated coverage probability for θ j is then
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Pr(I j  θ j ) = ∑ c j/m. (The symbol  reads ’covers’). For all of the parameters
in Table 2 the coverage percentage lay between 92.5 and 97.5% (not shown).
9.1 Some remarks onmodel fitting
Remark 1. Throughout the simulation study (and subsequent data analysis), a user-
written R script was used which called the nlm procedure to fit the model. This is a
numerical optimization routine with which we are familiar. It can use analytical first
and second derivatives, but we allowed the routine to compute numerical derivatives
and an approximation to the hessian. This approach has worked well for us in the
past. As with any new model, it is important to be careful in the selection of the
true values, to be simulated from, which must generate 0 < t < ∞ via the inverse
distribution function transform (t = F−1(u), where u ∼ Uniform(0, 1)). Similarly,
with the selection of starting values which must generate a valid interior point in the
parameter space. A poor choice of starting values may lead nlm to a false start with
no progress from the starting values. This situation was trapped in the user-written R
script. At the time of writing, we do not have experience of other methods of fitting
these models.
Remark 2. In the case of the TDL +MPR + GF models, the simulation study suggests
that at least 20 observations per parameter are required for successful fitting and
estimation of the corresponding variance covariance matrix. In general, studies of
survival data with small sample sizes are unlikely to be of great interest. The minimum
TDL + MPR + GF model with a single covariate in the scale and shape parameters
requires 5 parameters. In the Gastric Tumour Study (1982), there were 90 observations
(45 per group) and the 5 parameter TDL + MPR + GF model fitted easily. However,
the censoring rates were low: 4.4% in one group and 13.2% in the other.
Remark 3. The distribution of the estimated parameters appeared as a uni-modal,
symmetric, histogram—approximately Normal in shape, regardless of the sample
size studied. Exceptions occurred when the simulation produced outliers due to non-
convergence of the numerical optimization routine. Such outliers were produced more
often in scenarios where the sample size was small and the censoring rate high. When
the outliers were removed, the Normal-like distribution re-emerged. 
The simulation study included all of the models listed in Table 3 and the results for
other models (not shown) follow a similar pattern.
10 Analysis of lung cancer data
10.1 Data analysed
We turn now to analyse the Lung Cancer dataset (Wilkinson 1995). This was a multi-
source, population-based, study of 855 incident cases diagnosed in Northern Ireland,
UK, betweenOctober 1st, 1991 and September 30th, 1992. The patients were followed
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Fig. 3 NI lung cancer study: overall Kaplan–Meier survival curve (left panel) and by treatment (right panel)
for almost 2 years and survival time was computed as the time from first diagnosis to
death or censoring. Some 673 (77%) patients had died by the censoring date (30thMay,
1993), leaving 182 (23%) censored. We adopt the conventional 5% level of statistical
significance in what follows.
10.2 Analysis of treatment
Figure 3 (left panel) shows the Kaplan–Meier (KM) estimator of overall survival from
incident lung cancer. Half the patients were dead by 6 months and more than half
(51.6%) were allocated to the palliative care group at the time of diagnosis, indicating
that no curative treatment was planned. Typically, such poor prognosis results from
late diagnosis.
The oncologists were principally interested in the effect of treatment and in which
model(s) fitted the treatment survival data, as later, these would be adjusted for the
effects of the other measured covariates.
The right panel of Fig. 3 shows the KM estimator by treatment category (Surgery,
Chemotherapy, Radiotherapy, Chemo. + Radio., Palliative care). Surgical treatment
has the best survival pattern and palliative care the worst. The observed survival tracks
do not appear to follow a proportional hazards model—notice the late crossing haz-
ards between chemotherapy and radiotherapy and the convergent behaviour of the
combined therapy group.
As a first step, we illustrate fitting the models with only the treatment covariate.
Table 3 shows the results of fitting all 21 models in the XGTDL family in terms of
the type of parameters fitted, the log-likelihood, the AICs obtained, and the number
of parameters fitted. Within a model class (e.g. Weibull) the various model types form
a hierarchy in terms of the number of parameters fitted, which is the same across the
classes (Weibull, LPH and TDL); LAL being the exception.
Inspection of Table 3 shows that including Gamma frailty in the models results in
statistically significant decreases in the observed AICs throughout. For example, in
the TDL class a decrease (dAIC) of 22.99 units is obtained between the basic Weibull
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model (3932.32) and the same model with Gamma frailty included (3888.34), for
the addition of just 1 additional parameter. Increasing complexity, by including a
dispersion model, also improves model fit throughout the table, although the gains,
while still statistically significant, are more modest.
Moving to the MPR modelling scheme (without Gamma frailty) yields models
which are close to the basic models with Gamma frailty. For example, in the TDL
class the TDL + DM model has an AIC of 3887.20 while the AIC of the TDL +
MPR model is 3888.95. In the table, only in the LPH class, is the LPH + MPR model
superior to the LPH + DM (dAIC = 2.78). Both types model shape: the MPR model
by person-specific covariates influencing the shape parameter and the DM model by
Gamma frailty distributions stratified by covariates. That these are different measures
of shape is evidenced in the table by the models which support Gamma frailty and
MPR parameters. In fact the best model in 3 of the 4 classes is the MPR + GF model.
Note that the addition of a dispersion model to a non-MPRmodel reduces the AICs by
an significant quantity. But when the model is MPR, the reduction is not statistically
significant. Overall, the conclusion is that the WB + MPR + GF model is a good
working assumption.
In these data, the optimum AIC (= 3875.89) is provided by the WB + MPR + GF
model which is substantially better than the AIC (= 3896.24) produced by the WB +
MPR model which was used to analyse treatment in Burke and MacKenzie (2017).
We note that none of the new models proposed fit the data as well as the WB +MPR +
GF comparator. The nearest contender is the TDL +MPR + GF model with an AIC of
3883.70 which, however, is also significantly better than the WB + MPR model. We
conclude that while the Gastric Cancer data required a non-PH base hazard function
the Lung Cancer data do not.
10.3 Covariate adjustment
TheNI Lung Cancer Study is an observational, population-based, study, and therefore,
we adjust the treatment effects for the other measured covariates, using the models
which performed well in the previous section, namely, the WB +MPR + GF and TDL
+ MPR + GF models.
The results are shown in Table 4 for fitting the full and reduced MPR + GF models
in the Weibull and TDL classes. There are several interesting findings. First, the two
models are re-assuringly broadly similar in relation to themagnitude and interpretation
of the effects in the scale and shape regressions. Second,we note the large improvement
inAICwhen compared to anymodel involving treatment alone (cf. Table 4), indicating
that non-treatment covariates are clearly important. Third,we note thatmore covariates
influence the scale than the shape—twice as many in the Weibull case. This is a
common finding in MPR modelling. On eliminating the redundant effects from the
full models in Table 5, we reach dAICs of 23.36 and 20.42 for the Weibull and TDL
models, respectively, indicating that the reduced models have significantly improved
fit. We note, however, that in these reduced models the shape parameters cannot be
ignored, dAIC = 9.80 for the Weibull and dAIC = 4.11 for the TDL, respectively, and
thus the shape effects are less influential in the TDL + MPR + GF model.
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Table 3 AICs for XGTDL family and Weibull comparator models fitted using the treatment covariate
Table 4 Comparison of Weibull and TDL (MPR + GF) models fitting all nine covariates
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Table 5 Unadjusted and adjusted treatment comparisons showing mles (S.E.): adjusted for covariates in
the reduced models
Table 5 compares unadjusted and adjusted treatment effects in the MPR + GFmod-
els. The adjustment is for the effect of the covariates (case-mix) included in the reduced
models (see Table 4). The pattern is the same for both models, namely, adjustment
for the effects of case-mix reduces the beneficial effects of surgery, chemotherapy and
radiotherapy observed in the unadjusted analysis, but enhances the effect of the com-
bined therapy. However, since only 34 cases received combined therapy the overall
effect of adjustment is to reduce the benefit attributable to treatment. That the large
benefit in the combined therapy group is an early effect, attenuated later as follow-up
progresses, is evidenced by the large positive effect in the shape regression (coefficients
not shown).
11 Discussion
The non-PH GTDL family is of course not the only way to model non-PH data, but
it was the use of a member of this family in the crossing hazards example that led,
in part, to the broader idea of modelling the shape parameter systematically with
the usual scale parameter in survival distributions. A parallel idea was to routinely
incorporate frailty because, realistically, survival data do not always conform to the
proportional hazards assumption and important covariate information may be missed,
even in randomised controlled trials using minimization. Accordingly, the extension
to the XGTDL family is a natural statistical modelling development.
Whilst frailty modelling is now relatively well established, the idea of modelling
shape symmetrically with scale (the MPR idea) is less well accepted in the survival
literature. This paper demonstrates the potential benefits of adopting a MPR approach
and corroborates our previous work in this area (Burke and MacKenzie 2017; Peng
et al. 2020). Moreover, we have also demonstrated the importance of including both
the frailty concept and the MPR approach, a finding which suggests that the MPR
model captures a form of time dependence which classical frailty models cannot.
Although this is only one set of data, our experience with other data leads us to
suggest that the addition of Gamma frailty and MPR regression to a base model will
often be a good general starting place from which to analyse non-PH survival data.
When we embarked on this extension the question, as to whether all survival distri-
butions could be extended easily toMPR form, was open.With the logistic accelerated
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life (LAL) class, we encountered problems when developing the MPR extension. The
difficulty may result simply from the functional form of the hazard in AL models and
we continue to investigate this topic in our laboratory. Meanwhile, we hope the mod-
els developed thus far in the XGTDL family will be of use to the survival modelling
community.
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